0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Evidence Synopsis | 
Irene Tramacere, PhD; Cinzia Del Giovane, PhD; Graziella Filippini, MD
JAMA. 2016;315(4):409-410. doi:10.1001/jama.2015.18984.

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;314(21):2226. doi:10.1001/jama.2015.16086.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(11):1108. doi:10.1001/jama.2015.11140.

Clinical Crossroads | 
Kevin P. Hill, MD, MHS
JAMA. 2015;313(24):2474-2483. doi:10.1001/jama.2015.6199.
Includes: CME, Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2015;313(21):2114. doi:10.1001/jama.2015.5672.

Editorial | 
Stephen L. Hauser, MD
JAMA. 2015;313(3):251-252. doi:10.1001/jama.2014.18150.

Preliminary Communication |  FREE
Richard K. Burt, MD; Roumen Balabanov, MD; Xiaoqiang Han, MD; et al.
JAMA. 2015;313(3):275-284. doi:10.1001/jama.2014.17986.
Includes: Supplemental Content

Original Investigation |  FREE
Nikolai Madrid Scheller, MB; Henrik Svanström, MSc; Björn Pasternak, MD, PhD; et al.
JAMA. 2015;313(1):54-61. doi:10.1001/jama.2014.16946.
Includes: Supplemental Content

Lab Reports | 
Tracy Hampton, PhD
JAMA. 2014;312(21):2202. doi:10.1001/jama.2014.16227.

news@JAMA | 
JAMA. 2014;311(13):1281. doi:10.1001/jama.2014.2920.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Neurology
Original Investigation  | 
Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders A Systematic Review and Meta-analysis
Valentina Damato, MD; Amelia Evoli, MD; Raffaele Iorio, MD, PhD
JAMA Neurology
Editorial  | 
Perspectives on Safety and Efficacy—The BOLD Phase 2 Extension Study of Siponimod in Relapsing-Remitting Multiple Sclerosis
Edward R. Hammond, MD, PhD, MPH
JAMA Neurology
Original Investigation  | 
Safety and Efficacy of Siponimod (BAF312) in Patients With Relapsing-Remitting Multiple Sclerosis Dose-Blinded, Randomized Extension of the Phase 2 BOLD Study
Ludwig Kappos, MD; David K. B. Li, MD; Olaf Stüve, MD; et al.
JAMA Neurology
Editorial  | 
Cortical Volume Loss and Neurologic Dysfunction in Multiple Sclerosis
Michael K. Racke, MD; Jaime Imitola, MD